As the life sciences field evolves, so do the job opportunities it offers.
British Prime Minister Margaret Thatcher said, “if you want something said, ask a man; if you want something done, ask a woman.”
Femtech or “Female technology” is a phrase applied to software, diagnostics, products and services that use technology to target women’s health. This includes reproductive health, pregnancy and nursing care, pelvic and uterine care, general healthcare and much more.
The economic burden for women’s diseases is predicted to surpass $500 billion. Most women’s healthcare products are packaged and advertised as beauty products.
Most spending on other diseases are focused on male research, which is in fact separate from research funding on explicitly male-oriented diseases.
Since men’s health solutions are extremely different than women’s health, it’s time to focus on gender-specific funding and technologies.
In our recent webinar, “Femtech: Empowering Women’s Health,” featuring Lindsay Meisel from Ava Science and Jackie Dayton from Kindara, we explain in-depth the current trends, opportunities and barriers in the Femtech industry.
If you missed the webinar, don’t worry. Below is a recap of what we discussed.
Trends in the Global Femtech Market
Topics: Life Sciences
Today’s blog post is an introduction to biohacking—the market, technology, products, challenges and opportunities that are making a significant impact across many industries—adapted from our recent webinar, “Biohacking—Analyst Conversation,” featuring analysts Smruti Munshi and Antonio Regalado.